𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The treatment of multiple myeloma with docetaxel (an ECOG study)

✍ Scribed by William R. Friedenberg; David Graham; Philip Greipp; Emily Blood; Robert D. Winston

Book ID
108403273
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
43 KB
Volume
27
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Multiple myeloma: An immunoclinical stud
Multiple myeloma: An immunoclinical study of disease and response to treatment
✍ P. W. Thavasu; R. K. Ganjoo; S. A. Maidment; S. B. Love; A. H. Williams; J. S. M πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 826 KB

Plasma cytokines and immune markers were assessed during the clinical management of 42 patients with multiple myeloma, MM. Of the patients 22/42 (all with progressive disease) were studied from the time of diagnosis, through various treatment regimes, to remission, progression or death. 5/42 patient

Aclacinomycin A in the treatment of mult
Aclacinomycin A in the treatment of multiple myeloma: A Southwest Oncology Group study
✍ Chatchada Karanes; John Crowley; Laxmidas Sawkar; Bill L. Tranum; William J. Hic πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 294 KB

Fifty-two patients with progressive resistant multiple myeloma were entered in this Southwest Oncology Group Phase II study, using weekly intravenous Aclacinomycin A. Of forty-three evaluable patients for response, there was one partial remission of 2 years duration and two sustained clinical improv